GlaxoSmithKline Consumer Nigeria Overview

  • Year Founded
  • 1971

Year Founded

  • Status
  • Public

  • Employees
  • 51


  • Stock Symbol

Stock Symbol

  • Share Price
  • $0.02
  • (As of Friday Closing)

GlaxoSmithKline Consumer Nigeria General Information


GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Corporate Office
  • GSK House, 1, Industrial Avenue
  • Ilupeju
  • Lagos, 100252
  • Nigeria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Consumer Nigeria Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $23.6M 1.2B 963K

GlaxoSmithKline Consumer Nigeria Financials Summary

In Thousands,
TTM 30-Jun-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV (25,309) (20,571) (2,952) 2,662
Revenue 39,877 59,466 54,534 55,525
EBITDA 1,891 2,446 3,136 3,775
Net Income 1,657 1,807 1,600 1,622
Total Assets 39,983 65,641 63,449 59,755
Total Debt 0 0 4 296
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Consumer Nigeria Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GlaxoSmithKline Consumer Nigeria‘s full profile, request access.

Request a free trial

GlaxoSmithKline Consumer Nigeria Comparisons

HQ Location
Total Raised
Post Valuation
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical
Lagos, Nigeria
51 As of 2022


re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labo
Ahmedabad, India
00000 As of 0000
0000 000.00


t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
Basel, Switzerland
00000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GlaxoSmithKline Consumer Nigeria Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zydus Lifesciences Corporation Ahmedabad, India 00000 000.00 0000 000.00
Sandoz International Corporation Basel, Switzerland 00000 00000000
Mallinckrodt Formerly PE-Backed Dublin, Ireland 0000 00.000 0000000000.
Dr. Reddy's Laboratories Corporation Hyderabad, India 00000 00000 000000 - 000 00000
Takeda Pharmaceutical Company Corporation Tokyo, Japan 00000 0000 000000000 0000
You’re viewing 5 of 26 competitors. Get the full list »

GlaxoSmithKline Consumer Nigeria Executive Team (1)

Name Title Board Seat Contact Info
Kunle Oyelana Managing Director
To view GlaxoSmithKline Consumer Nigeria’s complete executive team members history, request access »

GlaxoSmithKline Consumer Nigeria Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »